Asian Society of Gynecologic Oncology International Workshop 2018.
Tae Wook KongHee-Sug RyuSeung Cheol KimTakayuki EnomotoJin LiKenneth H KimSeung-Hyuk ShimPeng Hui WangSuwanit TherasakvichyaYusuke KobayashiMaria LeeTing Yan ShiShin Wha LeeMikio MikamiSatoshi NagaseMyong Cheol LimJianliu WangSarikapan WilailakSang-Wun KimSook Hee HongDavid Shao Peng TanMasaki MandaiSuk-Joon ChangRuby Yun-Ju HuangKimio UshijmaJung-Yun LeeXiaojun ChenKazunori OchiaiTaek Sang LeeBingyi YangFarhana KalamQiaoying LvMohd Faizal AhmadMuhammad Rizki YaznilKanika Batra ModiManatsawee ManopunyaDae Hoon JeongArb Aroon LertkhachonsukHyun Hoon ChungHidemichi WatariSeob JeonPublished in: Journal of gynecologic oncology (2019)
The Asian Society of Gynecologic Oncology International Workshop 2018 on gynecologic oncology was held in the Ajou University Hospital, Suwon, Korea on the 24th to 25th August 2018. The workshop was an opportunity for Asian doctors to discuss the latest findings of gynecologic cancer, including cervical, ovarian, and endometrial cancers, as well as the future of fertility-sparing treatments, minimally invasive/radical/debulking surgery, radiotherapy, chemotherapy, targeted therapy, and immunotherapy. Clinical guidelines and position statement of Asian countries were presented by experts. Asian clinical trials for gynecologic cancers were reviewed and experts emphasized the point that original Asian study is beneficial for Asian patients. In Junior session, young gynecologic oncologists presented their latest research on gynecologic cancers.
Keyphrases
- endometrial cancer
- minimally invasive
- clinical trial
- palliative care
- early stage
- squamous cell carcinoma
- radiation therapy
- newly diagnosed
- papillary thyroid
- childhood cancer
- coronary artery disease
- coronary artery bypass
- percutaneous coronary intervention
- lymph node
- neoadjuvant chemotherapy
- open label
- double blind
- peritoneal dialysis
- placebo controlled